MicroCHIPS heads new scientific board with Tamborlane

By Mass High Tech staff

Yale to work with Icagen, Pfizer on novel pain treatments [May 2, 2011]

Alnylam RNAi patent progresses in Europe [April 20, 2009]

Dyax trims pipeline, cuts 60 jobs to focus on DX-88 [March 30, 2009]

Hologic wins FDA OK for two new HPV tests [March 13, 2009]

Yale endocrinologist and diabetes researcher William V. Tamborlane has been named the founding member of the newly formed MicroCHIPS Inc. scientific advisory board.

The board will offer support for the company’s development of biosensing and drug delivery devices for diabetes, osteoporosis and other diseases, MicorCHIPS officials reported.

Tamborlane graduated from Georgetown University with a bachelor of science degree and a doctrate of medicine degree.

Tamborlane joins the MicroCHIPS scientific advisory board as professor and chief of pediatric endocrinology and diabetes at Yale School of Medicine. He has served as a member of both the U.S. Food and Drug Administration’s Endocrine Advisory Board and the National Board of Directors of the American Diabetes Association.

MicroCHIPS, located in Bedford, addresses chronic medical conditions using the company’s microreservoir technology initially created at MIT.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.